Skip to content
← Back to this collection

PUBLICATIONS · 33001135

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2020 Nov 1
First author
Yau T

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2021 Jan 1;7(1):140. doi: 10.1001/jamaoncol.2020.6961.
    note
    Source null
    related pmid
    33270092
    relationship
    Erratum in

Authors and identifiers

  1. name
    Yau T
    type
    Author
  2. name
    Kang YK
    type
    Author
  3. name
    Kim TY
    type
    Author
  4. name
    El-Khoueiry AB
    type
    Author
  5. name
    Santoro A
    type
    Author
  6. name
    Sangro B
    type
    Author
  7. name
    Melero I
    type
    Author
  8. name
    Kudo M
    type
    Author
  9. name
    Hou MM
    type
    Author
  10. name
    Matilla A
    type
    Author
  11. name
    Tovoli F
    type
    Author
  12. name
    Knox JJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Yau T
    type
    Author
  2. name
    Kang YK
    type
    Author
  3. name
    Kim TY
    type
    Author
  4. name
    El-Khoueiry AB
    type
    Author
  5. name
    Santoro A
    type
    Author
  6. name
    Sangro B
    type
    Author
  7. name
    Melero I
    type
    Author
  8. name
    Kudo M
    type
    Author
  9. name
    Hou MM
    type
    Author
  10. name
    Matilla A
    type
    Author
  11. name
    Tovoli F
    type
    Author
  12. name
    Knox JJ
    type
    Author
bibliography ids
  1. nci-bib-6e9f11b8e859a06c70b70b21
book metadata
content sha256
3303e95fd2e1cb1f64a3484ebaf108d97c0d5d63a94f61718a7631d8f866ff66
document type
citation
dois
  1. 10.1001/jamaoncol.2020.4564
electronic publication date
display
2020 Nov 12
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:33001135
immutable id
pubmed:33001135@3303e95fd2e1cb1f64a3484ebaf108d97c0d5d63a94f61718a7631d8f866ff66
journal
abbreviation
JAMA Oncol
issn electronic
2374-2445
issn print
2374-2437
issue
11
name
JAMA oncology
nlm unique id
101652861
pages
e204564
volume
6
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2021 Jan 1;7(1):140. doi: 10.1001/jamaoncol.2020.6961.
    note
    Source null
    related pmid
    33270092
    relationship
    Erratum in
outcomes validated
false
pmid
33001135
provenance
batch id
9bca82d1bba2b27adc79
provider
NCBI PubMed ESummary
record sha256
87e64bf1d71becdd018aea9660469291a8e8ced177ed6b6a4b3ac9bb4f2401eb
response sha256
c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
retrieved at
2026-09-09T23:47:56.131551+00:00
publication date
display
2020 Nov 1
precision
day
year
2020
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33001135/
title
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial.

Preserved source evidence · Not medical advice